phenol has been researched along with Leukemia in 3 studies
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Syringic acid (SA) is an active carcinogenesis inhibitor; however, the low bioavailability and unstable functional groups hinder its activity." | 5.91 | In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells. ( Cheemanapalli, S; Iyyappan, Y; Kanagaraj, S; Mahesh, Y; Palaniappan, C; Yarrappagaari, S, 2023) |
| "Hydroquinone (HQ) produced renal adenomas in male F344 rats, and these tumors appeared to arise from areas of spontaneous progressive nephropathy; the nephropathy itself has been found to be enhanced by HQ." | 4.79 | Analysis of studies related to tumorigenicity induced by hydroquinone. ( English, JC; Verna, L; Whysner, J; Williams, GM, 1995) |
| "Syringic acid (SA) is an active carcinogenesis inhibitor; however, the low bioavailability and unstable functional groups hinder its activity." | 1.91 | In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells. ( Cheemanapalli, S; Iyyappan, Y; Kanagaraj, S; Mahesh, Y; Palaniappan, C; Yarrappagaari, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheemanapalli, S | 2 |
| Palaniappan, C | 2 |
| Mahesh, Y | 2 |
| Iyyappan, Y | 2 |
| Yarrappagaari, S | 2 |
| Kanagaraj, S | 2 |
| Whysner, J | 1 |
| Verna, L | 1 |
| English, JC | 1 |
| Williams, GM | 1 |
| Smith, MT | 1 |
| Robertson, ML | 1 |
| Yager, JW | 1 |
| Eastmond, DA | 1 |
2 reviews available for phenol and Leukemia
| Article | Year |
|---|---|
Analysis of studies related to tumorigenicity induced by hydroquinone.
Topics: Adenoma; Animals; Carcinogenicity Tests; Female; Humans; Hydroquinones; Kidney Neoplasms; Leukemia; | 1995 |
Role of metabolism in benzene-induced myelotoxicity and leukemogenesis.
Topics: Animals; Benzene; Biotransformation; Bone Marrow; Catechols; Cells, Cultured; Cytochrome P-450 Enzym | 1990 |
1 other study available for phenol and Leukemia